MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
13.24
-0.17
-1.27%
After Hours: 13.21 -0.03 -0.23% 19:59 03/13 EDT
OPEN
13.67
PREV CLOSE
13.41
HIGH
14.35
LOW
13.23
VOLUME
423.64K
TURNOVER
--
52 WEEK HIGH
69.97
52 WEEK LOW
12.35
MARKET CAP
169.39M
P/E (TTM)
-0.6585
1D
5D
1M
3M
1Y
5Y
1D
Tonix Pharmaceuticals Holding (TNXP) Q4 Loss Deepens Community Concerns Despite Revenue Progress
Simply Wall St · 21h ago
Tonix Pharmaceuticals Holding Corp. publishes investor presentation on TONMYA fibromyalgia launch and USD 208 million cash position
Reuters · 21h ago
Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch
Benzinga · 1d ago
Tonix Pharmaceuticals Q4 revenue more than doubles, net loss widens
Reuters · 1d ago
Tonix Pharmaceuticals GAAP EPS of -$3.98 misses by $0.82, revenue of $5.39M beats by $2.42M
Seeking Alpha · 1d ago
Tonix Pharmaceuticals reports Q4 EPS ($3.98) vs. ($9.77) last year
TipRanks · 1d ago
*Tonix Pharmaceuticals 4Q Rev $5.4M >TNXP
Dow Jones · 1d ago
*Tonix Pharmaceuticals Sees Funding Sufficient Into 1Q27 >TNXP
Dow Jones · 1d ago
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.